Next Article in Journal
Special Issue: “Updates on HBV Infection”
Previous Article in Journal
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Previous Article in Special Issue
Fluoroquinolone-Transition Metal Complexes: A Strategy to Overcome Bacterial Resistance
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 10
Issue 3
10.3390/microorganisms10030579
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Plasmid-Mediated Quinolone Resistance (PMQR) in Two Clinical Strains of Salmonella enterica Serovar Corvallis

by
Xenia Vázquez
1,2,
Javier Fernández
2,3,4,5,
Silvia Hernáez
6,
Rosaura Rodicio
2,7,† and
Maria Rosario Rodicio
1,2,*,†
1
Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo (UO), 33006 Oviedo, Spain
2
Grupo de Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain
3
Servicio de Microbiología, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain
4
Research & Innovation, Artificial Intelligence and Statistical Department, Pragmatech AI Solutions, 33003 Oviedo, Spain
5
Centro de Investigación Biomédica en Red-Enfermedades Respiratorias, 28029 Madrid, Spain
6
Servicio de Microbiología, Hospital Universitario de Álava (HUA), 01009 Álava, Spain
7
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo (UO), 33003 Oviedo, Spain
*
Author to whom correspondence should be addressed.
†
R.R. and M.R.R. have equally contributed to this study.
Microorganisms 2022, 10(3), 579; https://doi.org/10.3390/microorganisms10030579
Submission received: 30 December 2021 / Revised: 25 February 2022 / Accepted: 3 March 2022 / Published: 7 March 2022
(This article belongs to the Special Issue Quinolone Antibiotics: Insights, Challenges, and Risks)
Browse Figures
Versions Notes

Abstract

:
Non-typhoid serovars of Salmonella enterica are one of the main causes of bacterial food-borne infections worldwide. For the treatment of severe cases of salmonellosis in adults, fluoroquinolones are amongst the drugs of choice. They are categorized by the World Health Organization (WHO) as “critically important with highest priority in human medicine”. In the present study, two clinical S. enterica serovar Corvallis isolates (HUA 5/18 and HUA 6/18) from a Spanish hospital, selected on the basis of fluoroquinolone resistance, were characterized. The MICs of ciprofloxacin, determined by E-test, were 0.5 and 0.75 µg/mL for HUA 5/18 and HUA 6/18, respectively, and both were also resistant to pefloxacin but susceptible to nalidixic acid. Whole genome sequencing (WGS) of the isolates was performed with Illumina platform, and different bioinformatics tools were used for sequence analysis. The two isolates belonged to ST1541, and had the Thr57Ser substitution in the ParC protein which is also found in ciprofloxacin susceptible isolates. However, they harbored identical ColE plasmids of 10 kb carrying the qnrS1 gene. In these plasmids, the gene was flanked by defective versions of IS2-like and ISKra4-like insertion sequences. HUA 5/18 and HUA 6/18 were also phenotypically resistant to streptomycin, sulfonamides and tetracycline, with the responsible genes: strA, strB, sul2 and tet(A) genes, being located on a IncQ1 plasmid. ColE plasmids with the qnrS1 gene are widely spread among multiple serovars of S. enterica from different samples and countries. These mobilizable plasmids are playing an important role in the worldwide spread of qnrS1. Thus, their detection in hospitals is a cause of concern which deserves further attention.

1. Introduction

Salmonella enterica subsp. enterica serovar Corvallis, with antigenic formula 8,20:z4,z23, is a cause of food-borne disease in humans, which has been mainly linked to consumption of poultry meat and derived products. According to the last report of the European Union (EU) on zoonoses, this serovar ranked around the 40th position from 2017 to 2019 [1]. However, a higher incidence has been observed in particular countries, like Bulgaria, Denmark, Thailand, Japan and Brazil [2,3,4,5]. In addition, S. Corvallis isolates resistant to third generation cephalosporins, carbapenems, colistin and fluoroquinolones have been reported [2,3,5,6,7]. All these antimicrobials are listed by the World Health Organization (WHO) as “critically important for human medicine”, because of their application in the effective control of serious bacterial infections [8].
Fluoroquinolones are among the drugs of choice for the treatment of severe cases of salmonellosis in adults, and S. enterica resistant to these antimicrobials is amongst the high priority pathogens listed by WHO [9]. Fluoroquinolone resistance in S. enterica has been mainly associated with point mutations affecting the quinolone resistance determinant region (QRDR) of chromosomal genes encoding the subunits of DNA topoisomerase II (DNA gyrase; gyrA and gyrB) and DNA topoisomerase IV (parC and parD), which are involved in DNA replication and transcription. In Gram-negative bacteria, mutations usually occur in a sequential way, and have an additive effect. Thus, a point mutation affecting the QRDR of gyrA and leading to nalidixic acid resistance can be followed by additional mutations in gyrA and/or other target genes like parC, which, combined with the former, extends resistance to fluoroquinolones. Other chromosomal mutations, leading to decreased expression of outer membrane porins or to overexpression of multidrug efflux pumps, can also have an impact on susceptibility to quinolones by reducing the intracellular drug accumulation [10,11,12,13,14]. More recently, plasmid mediated quinolone resistance (PMQR) was detected, raising concerns about transferability of this important resistance. In Enterobacteriaceae, PMQR is conferred by qnr (qnrA, qnrB, qnrC, qnrD, qnrS and qnrVC), qep, oqxAB or aac(6′)-Ib-cr genes. The Qnr proteins, which are members of the pentapeptide-repeat family, protect DNA gyrase and DNA topoisomerase IV from fluoroquinolone inhibition; QepA and OqxAB are efflux pumps of the major facilitator superfamily (MFS) and the resistance-nodulation division family (RND), respectively, involved in the active expulsion of fluoroquinolones; and Aac(6′)-Ib-cr is a bifunctional acetyltransferase, capable of modifying both aminoglycosides and quinolones [15,16]. Although PMQR genes usually confer only low-level resistance to fluoroquinolones without concomitant resistance to quinolones, they provide a genetic background for selection of chromosomal mechanisms leading to higher resistance levels, apart from impairing treatment [13].
In the present study we investigated the genetic bases of quinolone and fluoroquinolone resistance in two clinical isolates of S. enterica serovar Corvallis detected in a Spanish hospital. For this, experimental approaches were combined with whole genome sequencing (WGS) followed by bioinformatics analysis.

2. Materials and Methods

2.1. Bacterial Isolates and Antimicrobial Susceptibility

Two S. Corvallis isolates, HUA 5/18 and HUA 6/18, selected for their ciprofloxacin resistance, were analyzed in the present study. They were recovered at the “Hospital Universitario de Álava” (HUA), Basque Country, Spain, from fecal samples of different patients, both with acute gastroenteritis. The bacteria were isolated on selective culture media (Selenite broth and Hecktoen agar; bioMerieux, Marcy l’Etoile, France) and identified by MALDI-TOF (Bruker Daltonics, Billerica, MA), according to the manufacturer’s instructions. Briefly, a small amount of inoculum from fresh colonies of the isolates was smeared on a polished steel MSP 96 target plate (Bruker Daltonik), overlaid with 1 μL of a saturated alfa-cyano-4-hydroxy-cinnamic acid (alfa-CHCA) matrix solution in 50% acetonitrile-2.5% trifluoroacetic acid (Bruker Daltonik), and air dried at room temperature. The spectra were then acquired by the mass spectrometer and compared with those included in the reference database using the BioTyper software. Susceptibility to antimicrobial agents was determined by automated MicroScan NC 53 (Beckman Coulter, CA, USA), complemented with Bauer–Kirby disk diffusion assays, using commercially available discs (Oxoid, Madrid, Spain). The following compounds, with the amount per disk in µg shown in parenthesis, were used: ampicillin (10), amoxicillin-clavulanic acid (30), cefepime (30), cefotaxime (30), cefoxitin (30), erthapenem (10), chloramphenicol (30), amikacin (30), gentamicin (10), kanamycin (30), streptomycin (10), tobramycin (10), azithromycin (15), nalidixic acid (30), ciprofloxacin (5), sulfonamides (300), tetracycline (30), trimethoprim (5), fosfomycin (300) and nitrofurantoin (300). MICs to nalidixic acid and ciprofloxacin were determined by E-test (bioMérieux, Marcy l’Étoile, France). In accordance with the EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines (https://eucast.org/clinical_breakpoints/ (accessed on 4 November 2021)), a 5 µg pefloxacin disk was included in the Bauer–Kirby assays, as surrogate to detect clinical resistance to fluoroquinolones. The reason for this is that the nalidixic acid disk used (30 µg) fails to effectively detect isolates with PMQR, and because of the overlap in the inhibition zone diameter (IZD) between wild-type isolates and isolates with low-level resistance observed for the 5 µg ciprofloxacin disk. Results were interpreted according to EUCAST or to CLSI (Clinical and Laboratory Standards Institute) guidelines [17], the latter in the case of NAL that is not contemplated by EUCAST.

2.2. Whole Genome Sequencing, Bioinformatics Analysis and Phylogenetic Relationships

Genomic DNA was purified from overnight cultures grown in Luria–Bertani (LB) broth, with the GenEluteTM Bacterial Genomic DNA Kit (Sigma-Aldrich; Merck Life Science, Madrid, Spain), following the manufacturer’s instructions. WGS was performed with Illumina at the “Centro de Investigación Biomédica”, La Rioja (CIBIR), Spain, to generate paired-end reads of 100–150 nt from PCR-free fragment libraries of 400–500 bp. De novo assembly of the reads was accomplished with the VelvetOptimiser.pl script implemented in the “on line” version of PLACNETw (https://omictools.com/placnet-tool/ (accessed on 6 June 2019)), which also allowed separating contigs of chromosomal and plasmid origin [18]. Relevant information related to the quality of the assemblies is shown in Table 1.
The assembled genomes of the isolates, deposited in GenBank under the accession numbers included in “Data Availability Statement” (see below), were annotated with the NCBI Prokaryotic Genome Annotation Pipeline (PGAP; https://www.ncbi.nlm.nih.gov/genome/annotation_prok/ (accessed on 17 May 2021)). For bioinformatics analysis, PLACNETw and different tools available at the Center for Genomic Epidemiology (CGE) of the Technical University of Denmark (DTU) were used (https://cge.cbs.dtu.dk/services/ (accessed on 8 November 2021)). These included MLST (v2.0.4), ResFinder (v4.1) and PlasmidFinder (v2.0.1) [19,20,21,22]. The phylogenetic relationships between the S. Corvallis isolates from HUA and 44 S. Corvallis isolates retrieved from databases were inferred using the CSI phylogeny tool (v1.4), available at the CGE website [23]. The pipeline was run with default parameters, using the genome of HUA 6/18 as the reference for SNP calling. Bootstrap support for the consensus phylogenetic tree relied on 1000 replicates [24]. The accession numbers of the genomes included in the phylogenetic analysis and the resulting SNP matrix are shown in Tables S1 and S2, respectively. The annotations of the resistance plasmids carrying either the qnrS1 gene or other resistance genes were manually curated with the aid of blastn, blastp (https://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 25 November 2021)) and CLONE Manager Professional (CmSuit9). The genetic organization of these plasmids was represented with EasyFig BLASTn (https://mjsull.github.io/Easyfig/ (accessed on 6 December 2021)).

3. Results and Discussion

HUA 5/18 and HUA 6/18 were recovered from feces of a 53 year-old female and a 6 year-old child with acute gastroenteritis, attended at a hospital in Northern Spain (Table 2). They were selected on the basis of resistance to fluoroquinolones (see below), and experimentally assigned to S. enterica serogroup C2 at the hospital. The assembly size of the sequenced genomes was of 4.89 Mb for both isolates (Table 1), with a GC content of approximately 52.1%. Serotyping and MLST performed in silico identified the isolates as S. Corvallis of sequence type ST1541. Five small plasmids, with sizes ranging from 2.2 to 11 kb, were shared by HUA 5/18 and HUA 6/18. They belonged to the IncQ1, ColE and ColpVC incompatibility groups, or had an unidentified replicon.
The two isolates were susceptible to nalidixic acid, with IZD of 20 mm in disk diffusion assays, and MICs of 3 and 4 µg/mL for HUA 5/18 and HUA 6/18, respectively. In contrast, the MICs of ciprofloxacin were 0.5 and 0.75 µg/mL for HUA 5/18 and HUA 6/18, respectively, well above the breakpoint of resistance established by EUCAST. In agreement with this, both were resistant to pefloxacin with an IZD of 12 mm around the 5 µg disk used in the Bauer–Kirby assay recommended by EUCAST to detect clinical resistance to fluoroquinolones.
As revealed by bioinformatics analysis, HUA 5/18 and HUA 6/18 contained the PMQR gene qnrS1, which is likely to account for the low-level ciprofloxacin resistance shown by the isolates. This gene has been previously found in clinical, veterinary and food-borne isolates of different S. enterica serovars, including S. Corvallis [6,25,26,27,28,29,30]. In S. enterica, qnrS1 has been located on plasmids belonging to different incompatibility groups, comprising IncN, IncHI2, IncR, IncX and ColE [26,27,31,32,33,34,35]. The isolates in this study carried the gene on ColE plasmids which were identical to each other and nearly identical (˃99.5%) to other fully sequenced plasmids found in clinical isolates of S. Typhimurium from the UK and Taiwan [36,37,38], and to plasmids of S. Corvallis and S. Typhimurium recovered in Japan from seafood imported from Thailand and Vietnam [25]. Like these other plasmids, they contain the mobA, mobB, mobC and mobD genes coding for mobilization proteins similar to those expressed by the E. coli pEC278 plasmid (accession number AY589571), and a rep gene which is more closely related to that of the E. coli ColRNA1 plasmid p15A (accession number V00309; [39]), (Figure 1A). Although ColE-like plasmids are not self-transmissible, they can be mobilized by co-resident conjugative plasmids due to the presence of oriT and mob genes [36]. Several environments have been reported for the qnrS1 gene, which was found to be associated with different mobile genetic elements, including Tn3-like transposons and insertion sequences ISEcl, IS26 and IS2-like [15,37]. The qnrS1 gene in the ColE plasmids analyzed herein, was preceded by two orfs which share the highest homology with orfs of the IS2-like elements ISAs17 and ISEcl1, and it was followed by a truncated ISKpn19 element of the ISKra4 family (Figure 1A).
None of the two isolates under study carried mutations in the QRDR of gyrA, gyrB and parE. However, both had AGC at codon 57 of parC, instead of ACC that is usually found in S. enterica. This change, which results in Thr57Ser substitution in the ParC protein, was previously found in quinolone-susceptible isolates of serovars S. Schwarzengrund, S. Hadar and S. Kentucky [40,41,42], as well as in a quinolone-susceptible isolate of S. Corvallis found in seafood imported in USA from Thailand [25] and in three quinolone-susceptible clinical isolates of the same serovar tested in our laboratory (unpublished results). These results argue against a role of the Thr57Ser substitution in resistance. Moreover, the genomes of 44 S. Corvallis isolates retrieved from databases to perform a phylogenetic analysis in the present study (see below), also had Ser instead of Thr as the 57th amino acid in ParC, although information on quinolone susceptibility of the latter isolates was not always available. Ser instead of Thr57 was also observed to be unrelated to quinolone resistance in the ParC protein of Shigella flexneri and of several E. coli serovars, indicating not only a cross-serovar but also a cross-species distribution of this polymorphism [43].
In addition to ciprofloxacin, HUA 5/18 and HUA 6/18 were also resistant to streptomycin, sulfonamides and tetracycline (Table 2). The responsible genes were identified as strA, strB, sul2 and tet(A), harbored by a IncQ1 plasmid of about 11 kb, which was identical in the two isolates (Figure 1B). Closely related plasmids were reported in several strains of S. Typhimurium recovered from humans, food-producing animals and foods in different countries, including Italy, UK and Taiwan (accession numbers CP004059, KU852461 and CP025338, for plasmids pNUC, pSTU288-2 and p11k, respectively) [44,45,46], and also in single strains of three other serovars, namely S. Reading, S. Schwarzengrund and S. Corvallis (accession numbers CP082735, CP081859 and CP044201, for unpublished plasmids pN16S0842, p16 an pAR-046-1, respectively). All these plasmids displayed more than 99.5% identity, with 100% coverage. In addition, the plasmids of HUA 5/18 and HUA 6/18 shared 99% identity with 74% coverage with pRFS1010 (of 8,684 bp), a multi-copy broad-host range plasmid of Escherichia coli, which is non-conjugative but can be mobilized by co-resident conjugative plasmids (accession number M28829); [47]. pRFS1010 is one of the most extensively studied IncQ1 plasmids, and is considered as a prototype for the IncQ group [48]. The homologous region comprises genes involved in replication (repA, repB and repC), and mobilization (mobA, mobB and mobC), and also the strA, strB and sul2 genes. In contrast, the tetR and tet(A) genes are absent in pRFS1010, but present in the S. Corvallis and closely related plasmids (Figure 1B). It has been proposed that the latter plasmids constitute a separate group of IncQ plasmids, which have evolved from pRFS1010 through acquisition of the tetR-tet(A) genes, characteristically carried by transposon Tn1721 [46]. As previously noticed for the homologous pSTU288-2 of S. Typhimurium [45], the GC content of the S. Corvallis plasmid (61.7%) is well above the GC content of the host strains (52.1%). Like in HUD 5/18 and HUD 6/18, both the ColE and the IncQ plasmids were found together in five closely related strains of S. Typhimurium obtained from humans and animals in Taiwan [44].
Finally, a phylogenetic tree was constructed with the two newly sequenced genomes of S. Corvallis and 44 other genomes available in public databases (Table S1), all with sequence type ST1541 which is the most commonly associated with this serovar. As shown in Figure 2, the clinical isolates from the Basque Country, which were nearly identical to each other, belong to a branch that also contains a single isolate from the UK (accession number AAFGXP010000001.1) whose origin has not been described, but which is also positive for the qnrS1 gene according to ResFinder. The two isolates in the present study were recovered from different patients with no travel history before the onset of the disease. They were obtained at about the same time, and could have been associated with a small outbreak, although information on a possible epidemiological link between the two patients was not available. In any case, it is interesting that closely related qnrS1-positive isolates, which differ by only 42–43 SNPs are circulating in two different countries, i.e., Spain and UK, indicating the international spread of such isolates.

4. Conclusions

Two clinical isolates of S. Corvallis with low-level resistance to ciprofloxacin: HUA 5/18 and HUA 6/18, carried the Thr57Ser substitution in the ParC protein, and a ColE1 plasmid bearing the qnrS1 gene. The Thr57Ser substitution in ParC was also found in susceptible isolates. Accordingly, the PMQR qnrS1 gene is likely to be responsible for the fluoroquinolone resistance phenotype of HUA 5/18 and HUA 6/18. Nearly identical qnrS1 positive isolates are circulating in different countries, consistent with their international spread.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/microorganisms10030579/s1, Table S1: Accession numbers of the genomes and additional information on the Salmonella enterica serovar Corvallis ST1541 isolates used for phylogenetic analysis in the present study. Table S2: Pairwise SNP distance matrix calculated from the genomes of two Salmonella enterica serovar Corvallis human isolates from a Spanish hospital and 44 isolates from other sources and countries.

Author Contributions

Conceptualization, J.F., R.R. and M.R.R.; methodology, X.V., J.F., S.H. and R.R.; investigation, X.V., J.F., S.H. and R.R.; visualization, X.V., R.R. and M.R.R.; validation, all authors; formal analysis, all authors.; resources, J.F., S.H. and M.R.R.; data curation, X.V.; writing—original draft preparation, X.V., R.R. and M.R.R.; writing—review and editing, all authors.; supervision, R.R. and M.R.R.; project administration, M.R.R.; funding acquisition, M.R.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by by project FIS PI17/00474 of the “Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad”, Spain, cofunded by European Regional Development Fund of the European Union: a way to making Europe. XV was the recipient of grant BP17-018 from the Program “Severo Ochoa” for support of Research and Teaching in the Principality of Asturias, Spain.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethic Committee of the Hospital Universitario Central de Asturias (protocol code CEImPA, with reference number 2021.531, 2 November 2021), which granted permission to access microbiological and clinical data related to the anonymized patients.

Informed Consent Statement

Not applicable.

Data Availability Statement

The genome sequences generated in the present study were deposited in GenBank under accession numbers JAHCQI000000000 and JAHCQJ000000000 for Salmonella enterica serovar Corvallis HUA 5/18 and HUA 6/18, respectively.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. European Food Safety Authority and European Centre for Disease Prevention and Control. The European Union One Health 2019 Zoonoses Report. EFSA J. 2021, 19, 6406. [Google Scholar] [CrossRef] [Green Version]
  2. Archambault, M.; Petrov, P.; Hendriksen, R.S.; Asseva, G.; Bangtrakulnonth, A.; Hasman, H.; Aarestrup, F.M. Molecular characterization and occurrence of extended-spectrum beta-lactamase resistance genes among Salmonella enterica serovar Corvallis from Thailand, Bulgaria, and Denmark. Microb. Drug Resist. 2006, 12, 192–198. [Google Scholar] [CrossRef]
  3. Asseva, G.; Petrov, P.; Ivanov, I.; Kantardjiev, T. Surveillance of human salmonellosis in Bulgaria, 1999–2004: Trends, shifts and resistance to antimicrobial agents. Eurosurveillance 2006, 11, 97–100. [Google Scholar] [CrossRef] [PubMed]
  4. Ben Aissa, R.; Al-Gallas, N. Molecular typing of Salmonella enterica serovars Enteritidis, Corvallis, Anatum and Typhimurium from food and human stool samples in Tunisia, 2001–2004. Epidemiol. Infect. 2008, 136, 468–475. [Google Scholar] [CrossRef]
  5. Yamatogi, R.S.; Oliveira, H.C.; Camargo, C.H.; Fernandes, S.A.; Hernandes, R.T.; Pinto, J.P.; Rall, V.L.; Araujo, J.P., Jr. Clonal relatedness and resistance patterns of Salmonella Corvallis from poultry carcasses in a Brazilian slaughterhouse. J. Infect. Dev. Ctries. 2015, 9, 1161–1165. [Google Scholar] [CrossRef] [Green Version]
  6. Cavaco, L.M.; Hendriksen, R.S.; Aarestrup, F.M. Plasmid-mediated quinolone resistance determinant qnrS1 detected in Salmonella enterica serovar Corvallis strains isolated in Denmark and Thailand. J. Antimicrob. Chemother. 2007, 60, 704–706. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Fischer, J.; Schmoger, S.; Jahn, S.; Helmuth, R.; Guerra, B. NDM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in Germany. J. Antimicrob. Chemother. 2013, 68, 2954–2956. [Google Scholar] [CrossRef] [Green Version]
  8. WHO. Critically Important Antimicrobials for Human Medicine; 6th Revision 2018; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
  9. Tacconelli, E.; Carrara, E.; Savoldi, A.; Harbarth, S.; Mendelson, M.; Monnet, D.L.; Pulcini, C.; Kahlmeter, G.; Kluytmans, J.; Carmeli, Y.; et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 2018, 18, 318–327. [Google Scholar] [CrossRef]
  10. Fabrega, A.; du Merle, L.; Le Bouguenec, C.; Jimenez de Anta, M.T.; Vila, J. Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella Typhimurium mutant. PLoS ONE 2009, 4, e8029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Hooper, D.C.; Jacoby, G.A. Mechanisms of drug resistance: Quinolone resistance. Ann. N. Y. Acad. Sci. 2015, 1354, 12–31. [Google Scholar] [CrossRef] [Green Version]
  12. Hopkins, K.L.; Davies, R.H.; Threlfall, E.J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int. J. Antimicrob. Agents 2005, 25, 358–373. [Google Scholar] [CrossRef]
  13. Jacoby, G.A. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 2005, 41 (Suppl. 2), S120–S126. [Google Scholar] [CrossRef] [Green Version]
  14. Ruiz, J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 2003, 51, 1109–1117. [Google Scholar] [CrossRef] [Green Version]
  15. Jacoby, G.A.; Strahilevitz, J.; Hooper, D.C. Plasmid-mediated quinolone resistance. Microbiol. Spectr. 2014, 2, 475–503. [Google Scholar] [CrossRef] [Green Version]
  16. Robicsek, A.; Jacoby, G.A.; Hooper, D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 2006, 6, 629–640. [Google Scholar] [CrossRef]
  17. CLSI. Performance standards for antimicrobial susceptibility testing. In CLSI Supplement M100; Clinical and Laboratory Standards Institute: Wayne PA, USA, 2019. [Google Scholar]
  18. Vielva, L.; de Toro, M.; Lanza, V.F.; de la Cruz, F. PLACNETw: A web-based tool for plasmid reconstruction from bacterial genomes. Bioinformatics 2017, 33, 3796–3798. [Google Scholar] [CrossRef]
  19. Bortolaia, V.; Kaas, R.S.; Ruppe, E.; Roberts, M.C.; Schwarz, S.; Cattoir, V.; Philippon, A.; Allesoe, R.L.; Rebelo, A.R.; Florensa, A.F.; et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J. Antimicrob. Chemother. 2020, 75, 3491–3500. [Google Scholar] [CrossRef]
  20. Carattoli, A.; Zankari, E.; Garcia-Fernandez, A.; Voldby Larsen, M.; Lund, O.; Villa, L.; Moller Aarestrup, F.; Hasman, H. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob. Agents Chemother. 2014, 58, 3895–3903. [Google Scholar] [CrossRef] [Green Version]
  21. Larsen, M.V.; Cosentino, S.; Rasmussen, S.; Friis, C.; Hasman, H.; Marvig, R.L.; Jelsbak, L.; Sicheritz-Ponten, T.; Ussery, D.W.; Aarestrup, F.M.; et al. Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 2012, 50, 1355–1361. [Google Scholar] [CrossRef] [Green Version]
  22. Zankari, E.; Allesoe, R.; Joensen, K.G.; Cavaco, L.M.; Lund, O.; Aarestrup, F.M. PointFinder: A novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J. Antimicrob. Chemother. 2017, 72, 2764–2768. [Google Scholar] [CrossRef] [Green Version]
  23. Kaas, R.S.; Leekitcharoenphon, P.; Aarestrup, F.M.; Lund, O. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS ONE 2014, 9, e104984. [Google Scholar] [CrossRef] [Green Version]
  24. Felsenstein, J. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985, 39, 783–791. [Google Scholar] [CrossRef]
  25. Akiyama, T.; Khan, A.A. Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates. FEMS Immunol. Med. Microbiol. 2012, 64, 429–432. [Google Scholar] [CrossRef] [Green Version]
  26. Chen, K.; Yang, C.; Dong, N.; Xie, M.; Ye, L.; Chan, E.W.C.; Chen, S. Evolution of ciprofloxacin resistance-encoding genetic elements in Salmonella. mSystems 2020, 5, e01234-20. [Google Scholar] [CrossRef]
  27. Garcia-Fernandez, A.; Fortini, D.; Veldman, K.; Mevius, D.; Carattoli, A. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 2009, 63, 274–281. [Google Scholar] [CrossRef]
  28. Murray, A.; Mather, H.; Coia, J.E.; Brown, D.J. Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland. J. Antimicrob. Chemother. 2008, 62, 1153–1155. [Google Scholar] [CrossRef]
  29. Sjolund-Karlsson, M.; Howie, R.; Rickert, R.; Krueger, A.; Tran, T.T.; Zhao, S.; Ball, T.; Haro, J.; Pecic, G.; Joyce, K.; et al. Plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica isolates, USA. Emerg. Infect. Dis. 2010, 16, 1789–1791. [Google Scholar] [CrossRef]
  30. Veldman, K.; Cavaco, L.M.; Mevius, D.; Battisti, A.; Franco, A.; Botteldoorn, N.; Bruneau, M.; Perrin-Guyomard, A.; Cerny, T.; De Frutos Escobar, C.; et al. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J. Antimicrob. Chemother. 2011, 66, 1278–1286. [Google Scholar] [CrossRef]
  31. Antunes, P.; Mourao, J.; Machado, J.; Peixe, L. First description of qnrS1-IncN plasmid in a ST11 Salmonella Enteritidis clinical isolate from Portugal. Diagn. Microbiol. Infect. Dis. 2011, 69, 463–465. [Google Scholar] [CrossRef]
  32. Cui, M.; Zhang, P.; Li, J.; Sun, C.; Song, L.; Zhang, C.; Zhao, Q.; Wu, C. Prevalence and characterization of fluoroquinolone resistant Salmonella isolated from an integrated broiler chicken supply chain. Front. Microbiol. 2019, 10, 1865. [Google Scholar] [CrossRef] [Green Version]
  33. Dolejska, M.; Villa, L.; Hasman, H.; Hansen, L.; Carattoli, A. Characterization of IncN plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli and Salmonella from animals, the environment and humans. J. Antimicrob. Chemother. 2013, 68, 333–339. [Google Scholar] [CrossRef]
  34. Guerra, B.; Helmuth, R.; Thomas, K.; Beutlich, J.; Jahn, S.; Schroeter, A. Plasmid-mediated quinolone resistance determinants in Salmonella spp. isolates from reptiles in Germany. J. Antimicrob. Chemother. 2010, 65, 2043–2045. [Google Scholar] [CrossRef]
  35. Kehrenberg, C.; Friederichs, S.; de Jong, A.; Michael, G.B.; Schwarz, S. Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis. J. Antimicrob. Chemother. 2006, 58, 18–22. [Google Scholar] [CrossRef]
  36. Hopkins, K.L.; Wootton, L.; Day, M.R.; Threlfall, E.J. Plasmid-mediated quinolone resistance determinant qnrS1 found in Salmonella enterica strains isolated in the UK. J. Antimicrob. Chemother. 2007, 59, 1071–1075. [Google Scholar] [CrossRef] [Green Version]
  37. Kehrenberg, C.; Hopkins, K.L.; Threlfall, E.J.; Schwarz, S. Complete nucleotide sequence of a small qnrS1-carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193. J. Antimicrob. Chemother. 2007, 60, 903–905. [Google Scholar] [CrossRef]
  38. Wu, J.J.; Ko, W.C.; Chiou, C.S.; Chen, H.M.; Wang, L.R.; Yan, J.J. Emergence of Qnr determinants in human Salmonella isolates in Taiwan. J. Antimicrob. Chemother. 2008, 62, 1269–1272. [Google Scholar] [CrossRef] [Green Version]
  39. Selzer, G.; Som, T.; Itoh, T.; Tomizawa, J. The origin of replication of plasmid p15A and comparative studies on the nucleotide sequences around the origin of related plasmids. Cell 1983, 32, 119–129. [Google Scholar] [CrossRef]
  40. Baucheron, S.; Chaslus-Dancla, E.; Cloeckaert, A.; Chiu, C.H.; Butaye, P. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob. Agents Chemother. 2005, 49, 862–863. [Google Scholar] [CrossRef] [Green Version]
  41. Kim, K.Y.; Park, J.H.; Kwak, H.S.; Woo, G.J. Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance. Int. J. Food Microbiol. 2011, 146, 52–56. [Google Scholar] [CrossRef]
  42. Weill, F.X.; Bertrand, S.; Guesnier, F.; Baucheron, S.; Cloeckaert, A.; Grimont, P.A. Ciprofloxacin-resistant Salmonella Kentucky in travelers. Emerg. Infect. Dis. 2006, 12, 1611–1612. [Google Scholar] [CrossRef]
  43. Lindstedt, B.A.; Aas, L.; Kapperud, G. Geographically dependent distribution of gyrA gene mutations at codons 83 and 87 in Salmonella Hadar, and a novel codon 81 Gly to His mutation in Salmonella Enteritidis. APMIS 2004, 112, 165–171. [Google Scholar] [CrossRef]
  44. Hong, Y.P.; Wang, Y.W.; Huang, I.H.; Liao, Y.C.; Kuo, H.C.; Liu, Y.Y.; Tu, Y.H.; Chen, B.H.; Liao, Y.S.; Chiou, C.S. Genetic relationships among multidrug-resistant Salmonella enterica serovar Typhimurium strains from humans and animals. Antimicrob. Agents Chemother. 2018, 62, e00213-18. [Google Scholar] [CrossRef] [Green Version]
  45. Hooton, S.P.; Timms, A.R.; Cummings, N.J.; Moreton, J.; Wilson, R.; Connerton, I.F. The complete plasmid sequences of Salmonella enterica serovar Typhimurium U288. Plasmid 2014, 76, 32–39. [Google Scholar] [CrossRef] [Green Version]
  46. Oliva, M.; Monno, R.; D’Addabbo, P.; Pesole, G.; Dionisi, A.M.; Scrascia, M.; Chiara, M.; Horner, D.S.; Manzari, C.; Luzzi, I.; et al. A novel group of IncQ1 plasmids conferring multidrug resistance. Plasmid 2017, 89, 22–26. [Google Scholar] [CrossRef]
  47. Scholz, P.; Haring, V.; Wittmann-Liebold, B.; Ashman, K.; Bagdasarian, M.; Scherzinger, E. Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. Gene 1989, 75, 271–288. [Google Scholar] [CrossRef]
  48. Loftie-Eaton, W.; Rawlings, D.E. Diversity, biology and evolution of IncQ-family plasmids. Plasmid 2012, 67, 15–34. [Google Scholar] [CrossRef]
Microorganisms 10 00579 g001 550
Figure 1. Genetic organization of the ColE (A) and IncQ1 (B) plasmids carried by Salmonella enterica serovar Corvallis isolates from a Spanish hospital. The alignments of the ColE and IncQ1 plasmids with pEC278 (accession number AY589571) and pRFS1010 (accession number M28829), respectively, were created with EasyFig BLASTn. The gray shading between regions reflects nucleotide sequence identities according to the scales shown at the right lower corner of the figures. The open reading frames (ORFs) are represented by arrows pointing to the direction of transcription and having different colors according to their function: red, resistance; yellow, plasmid replication; brown, mobilization; blue, insertion sequences; grey, other roles; white, hypothetical proteins. Vertical boxes indicate truncated (pale blue) and intact (dark blue) inverted repeats of IS2-like and ISKar4-like elements, respectively. The mobA gene in the ColE plasmids (pale brown) partially (mobC) or totally (mobB and mobD) overlaps the other mob genes. The mobA gene of the IncQ plasmids (pale brown) overlaps with mobB and repB.
Figure 1. Genetic organization of the ColE (A) and IncQ1 (B) plasmids carried by Salmonella enterica serovar Corvallis isolates from a Spanish hospital. The alignments of the ColE and IncQ1 plasmids with pEC278 (accession number AY589571) and pRFS1010 (accession number M28829), respectively, were created with EasyFig BLASTn. The gray shading between regions reflects nucleotide sequence identities according to the scales shown at the right lower corner of the figures. The open reading frames (ORFs) are represented by arrows pointing to the direction of transcription and having different colors according to their function: red, resistance; yellow, plasmid replication; brown, mobilization; blue, insertion sequences; grey, other roles; white, hypothetical proteins. Vertical boxes indicate truncated (pale blue) and intact (dark blue) inverted repeats of IS2-like and ISKar4-like elements, respectively. The mobA gene in the ColE plasmids (pale brown) partially (mobC) or totally (mobB and mobD) overlaps the other mob genes. The mobA gene of the IncQ plasmids (pale brown) overlaps with mobB and repB.
Microorganisms 10 00579 g001
Microorganisms 10 00579 g002 550
Figure 2. Phylogenetic tree showing the relationships between Salmonella enterica serovar Corvallis ST1541 isolates from a Spanish hospital and other S. Corvallis ST1541 isolates from different countries and sources (Table S1). The minimum and maximum numbers of SNPs are indicated (see Table S2). The branch containing the Spanish isolates (highlighted in bold) is enclosed in a rectangle, which includes information available for the isolates shown at the right of the figure (unk = unknown). The tree was constructed with the CSI Phylogeny, based on single nucleotide polymorphisms identified by using the genome of S. Corvallis HUA 6/18 as reference. Numbers at the nodes represent bootstrap values resulting from 1000 replicates.
Figure 2. Phylogenetic tree showing the relationships between Salmonella enterica serovar Corvallis ST1541 isolates from a Spanish hospital and other S. Corvallis ST1541 isolates from different countries and sources (Table S1). The minimum and maximum numbers of SNPs are indicated (see Table S2). The branch containing the Spanish isolates (highlighted in bold) is enclosed in a rectangle, which includes information available for the isolates shown at the right of the figure (unk = unknown). The tree was constructed with the CSI Phylogeny, based on single nucleotide polymorphisms identified by using the genome of S. Corvallis HUA 6/18 as reference. Numbers at the nodes represent bootstrap values resulting from 1000 replicates.
Microorganisms 10 00579 g002
Table
Table 1. Parameters related to the quality of the assemblies of the genomes of two clinical isolates of Salmonella enterica serovar Corvallis resistant to fluoroquinolones.
Table 1. Parameters related to the quality of the assemblies of the genomes of two clinical isolates of Salmonella enterica serovar Corvallis resistant to fluoroquinolones.
Isolate aKmerContigsN50Longest Contig
(bp)		Total bp
in Contigs		Contigs
>1 kb		LibraryCoverage
HUA 5/188578795,2302,081,4484,887,70422508 ± 12625×
HUA 6/1887131407,4291,548,5944,886,05146506 ± 12941×
a, Isolates are designated with the initials of the center which supplied them, followed by a serial number/last two numbers of the year of recovery. HUA, “Hospital Universitario de Álava”, Basque Country, Spain.
Table
Table 2. Origin, resistance properties and plasmid content of Salmonella enterica serovar Corvallis ST1541.
Table 2. Origin, resistance properties and plasmid content of Salmonella enterica serovar Corvallis ST1541.
Isolate aPatient
Sex b/Age		NAL-IZD c
(mm)		NAL-MIC c
(µg/mL)		CIP-MIC c
(µg/mL)		PEF-IZD c
(mm)		ParCResistance Phenotype d
Plasmid-Located
Resistance Genes		Plasmid Inc.
(Size in bp) e
HUA 5/18F/532030.512Thr57SerCIP, PEF, STR, SUL, TET
strA, strB, sul2, tet(A)
qnrS1		IncQ1 (11,044)*
ColE (10,036)*
nid (5,570; 5,284)*,*
ColpVC (2,179)
HUA 6/18F/62040.7512Thr57SerSTR, SUL, TET, CIP, PEF
strA, strB, sul2, tet(A)
qnrS1		IncQ1 (11,044)*
ColE (10,036)*
nid (5,570; 5,284)*,*
ColpVC (2,179)
a, HUA, “Hospital Universitario de Álava”, Basque Country, Spain. b, F, female. c, NAL, nalidixic acid; CIP, ciprofloxacin; PEF, pefloxacin; IZD, inhibition zone diameter; MIC, minimum inhibitory concentration. d, STR, streptomycin; SUL, sulfonamides; TET, tetracycline. e, Inc, incompatibility group, with resistance plasmids shown in bold; nid, Inc not identified; *, circularized plasmids.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Vázquez, X.; Fernández, J.; Hernáez, S.; Rodicio, R.; Rodicio, M.R. Plasmid-Mediated Quinolone Resistance (PMQR) in Two Clinical Strains of Salmonella enterica Serovar Corvallis. Microorganisms 2022, 10, 579. https://doi.org/10.3390/microorganisms10030579

AMA Style

Vázquez X, Fernández J, Hernáez S, Rodicio R, Rodicio MR. Plasmid-Mediated Quinolone Resistance (PMQR) in Two Clinical Strains of Salmonella enterica Serovar Corvallis. Microorganisms. 2022; 10(3):579. https://doi.org/10.3390/microorganisms10030579

Chicago/Turabian Style

Vázquez, Xenia, Javier Fernández, Silvia Hernáez, Rosaura Rodicio, and Maria Rosario Rodicio. 2022. "Plasmid-Mediated Quinolone Resistance (PMQR) in Two Clinical Strains of Salmonella enterica Serovar Corvallis" Microorganisms 10, no. 3: 579. https://doi.org/10.3390/microorganisms10030579

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop